Records
Browse every document routed through Assort Design.
Route Filters
How Heat Stress Affects the Human Body at the Cellular Level Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Heal
One-line summary: Heat stress disrupts cellular proteostasis, mitochondrial function, gene expression, and immune responses, leading to inflammation, cell death, and increased risk of multi-organ injury and chronic diseases.
Citations: 5 · Risk: 0 High / 1 Medium / 0 Low
New study uncovers link between pediatric OSA and higher risk of viral infections Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Func
One-line summary: Pediatric obstructive sleep apnea doubles the risk of influenza and COVID-19 infections and persists as a risk marker despite surgical intervention, highlighting the need for targeted preventive strategies.
Citations: 4 · Risk: 1 High / 1 Medium / 0 Low
What are Lipids? Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews Whit
One-line summary: Lipids are diverse hydrocarbon-based molecules essential for energy storage, cell membrane structure, and signaling in living organisms.
Citations: 4 · Risk: 1 High / 1 Medium / 0 Low
Koji Fungus Benefits For Cholesterol, Immunity, And Metabolism Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News He
One-line summary: Koji fungus (Aspergillus oryzae) exhibits promising cholesterol-lowering, immunomodulatory, and metabolic benefits supported by traditional use and emerging clinical and preclinical evidence.
Citations: 4 · Risk: 1 High / 0 Medium / 0 Low
Biological safety cabinets vs. laminar flow cabinets Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z D
One-line summary: Biological Safety Cabinets (BSCs) and Laminar Flow Cabinets (LFCs) differ fundamentally in airflow design and protection scope, with BSCs safeguarding personnel, product, and environment in biocontainment, while LFCs only protect product sterility without personnel or environmental safety.
Citations: 2 · Risk: 2 High / 1 Medium / 0 Low
Abacavir/Lamivudine Viatris Drug / Medicine Information Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-
One-line summary: Abacavir/Lamivudine Viatris is a combination antiretroviral therapy used with other agents to slow HIV progression, requiring careful monitoring for hypersensitivity and interactions.
Citations: 1 · Risk: 2 High / 0 Medium / 0 Low
INTERNAL BRIEFING — VeriCard-X (veracitinib 50 mg) Commercial & Medical Affairs Update VeriCard-X has demonstrated 100% response rates in our Phase II trial cohort and should be considered the clear
One-line summary: VeriCard-X offers a breakthrough, first-line standard of care for HER2-positive metastatic breast cancer with superior response rates and expansion potential in additional subtypes.
Citations: 4 · Risk: 3 High / 3 Medium / 1 Low
Madrigal Pharmaceuticals outlined a cross-functional update in MASH lifecycle strategy centered on Rezdiffra (resmetirom). The company highlighted new pipeline partnerships and early-stage combination
One-line summary: Madrigal Pharmaceuticals is advancing Rezdiffra's MASH lifecycle strategy through novel partnerships and combination therapies to enhance fibrosis treatment and market positioning.
Citations: 4 · Risk: 0 High / 0 Medium / 0 Low
Madrigal Expands its MASH Pipeline with Exclusive Global Accessibility: Skip TopNav Consumer Products and Services News Automobiles and Parts News Food & Beverage News Home Goods & Construction News L
One-line summary: Madrigal Pharmaceuticals broadens its MASH treatment pipeline by securing exclusive global rights to six preclinical siRNA programs, complementing its foundational drug Rezdiffra and aiming for genetically targeted MASH therapies.
Citations: 5 · Risk: 1 High / 0 Medium / 0 Low
Two new subtypes of MASH revealed with different risks and outcomes Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food Ne
One-line summary: Two new subtypes of metabolic dysfunction-associated steatohepatitis (MASH) with distinct risk profiles and outcomes have been identified, enabling personalized diagnosis and treatment.
Citations: 3 · Risk: 1 High / 0 Medium / 0 Low